TECOS enrolled 14,500 patients who were followed for up to three years, and concluded that Januvia had no increase compared to placebo in major adverse CV events, hospitalisation for heart failure or adverse events
Rapid transit (diarrhoea-predominant IBS) similarly disrupts the stable microbiome balance required to outcompete yeast
The Journal of Clinical Investigation , 130 (7), 38653884
Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)
The post describes dizziness as common during initiation but expected to improve within one to three weeks once the dose is held steady
Our customized treatments are designed to enhance recovery, optimize performance, support weight loss, and improve overall wellness